Althoff Keri N, Rebeiro Peter, Brooks John T, Buchacz Kate, Gebo Kelly, Martin Jeffrey, Hogg Robert, Thorne Jennifer E, Klein Marina, Gill M John, Sterling Timothy R, Yehia Baligh, Silverberg Michael J, Crane Heidi, Justice Amy C, Gange Stephen J, Moore Richard, Kitahata Mari M, Horberg Michael A
Johns Hopkins University, Baltimore, Maryland.
Clin Infect Dis. 2014 Apr;58(8):1185-9. doi: 10.1093/cid/ciu044. Epub 2014 Jan 23.
We estimated US Department of Health and Human Services (DHHS)-approved human immunodeficiency virus (HIV) indicators. Among patients, 71% were retained in care, 82% were prescribed treatment, and 78% had HIV RNA ≤200 copies/mL; younger adults, women, blacks, and injection drug users had poorer outcomes. Interventions are needed to reduce retention- and treatment-related disparities.
我们评估了美国卫生与公众服务部(DHHS)批准的人类免疫缺陷病毒(HIV)指标。在患者中,71%接受了持续治疗,82%接受了处方治疗,78%的患者HIV RNA≤200拷贝/毫升;年轻成年人、女性、黑人及注射吸毒者的治疗效果较差。需要采取干预措施来减少治疗持续率和治疗方面的差异。